LifeVantage Corp  

(Public, NASDAQ:LFVN)   Watch this stock  
Find more results for LFVN
4.00
+0.01 (0.25%)
Feb 21 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 3.94 - 4.16
52 week 2.86 - 6.84
Open 3.94
Vol / Avg. 0.00/29,400.00
Mkt cap 56.93M
P/E 22.79
Div/yield     -
EPS 0.18
Shares 14.23M
Beta 0.31
Inst. own 15%
May 8, 2018
Q3 2018 LifeVantage Corp Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Feb 16, 2018
LifeVantage Corp Annual Shareholders Meeting (Estimated)
Feb 7, 2018
Q2 2018 LifeVantage Corp Earnings Call - Webcast
Feb 7, 2018
Q2 2018 LifeVantage Corp Earnings Release
Feb 2, 2018
LifeVantage Corp Annual Shareholders Meeting
Jan 8, 2018
LifeVantage Corp at ICR Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '17) 2017
Net profit margin 3.07% 0.81%
Operating margin 4.70% 2.23%
EBITD margin - 3.05%
Return on average assets 13.45% 3.35%
Return on average equity 37.70% 12.77%
Employees 211 -
CDP Score - -

Address

9785 S Monroe St Ste 300
SANDY, UT 84070-4282
United States - Map
+1-801-4329000 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

LifeVantage Corporation is a science-based network marketing company. The Company focuses on helping people achieve their health, wellness and financial independence goals. The Company provides products and a financially rewarding direct sales business opportunity to customers and independent distributors seeking a healthy lifestyle and financial freedom. It sells its products to preferred customers, retail customers and independent distributors located in the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand and the United Kingdom. The Company engages in the identification, research, development and distribution of advanced nutraceutical dietary supplements and skin care products, including Protandim, its scientifically-validated dietary supplement; LifeVantage TrueScience, its line of anti-aging skin care products; Canine Health; Axio, its energy drink mixes, and PhysIQ.

Officers and directors

Garry Paul Mauro Independent Chairman of the Board
Age: 68
Bio & Compensation  - Reuters
Darren Jay Jensen President, Chief Executive Officer, Director
Age: 47
Bio & Compensation  - Reuters
Steven R. Fife Chief Financial Officer
Age: 58
Bio & Compensation  - Reuters
Charles J. Wach Chief Operating Officer
Age: 54
Bio & Compensation  - Reuters
Michelle Oborn-Virchow Senior Vice President of Human Resources
Age: 36
Bio & Compensation  - Reuters
Ryan Goodwin Chief Marketing Officer
Age: 40
Bio & Compensation  - Reuters
Kevin Stewart McMurray General Counsel
Age: 55
Bio & Compensation  - Reuters
Justin Rose Chief Sales Officer
Age: 48
Bio & Compensation  - Reuters
Raymond B. Greer Director
Age: 54
Bio & Compensation  - Reuters
Vinayak R. Hegde Director
Bio & Compensation  - Reuters